Cash flow arising from operating activities :
|
|
Net profit before tax |
2,072.83 |
Adjustments: |
|
Depreciation and amortisation expense |
2,811.68 |
Loss on sale/disposal/discard/impairment of fixed assets (net) |
25.11 |
Finance costs |
3,237.23 |
Provision for loss on impairment of goodwill |
35.06 |
Amortisation of Foreign Currency Monetary Item Translation Difference Account (FCMITDA) |
1,000.21 |
Provision for doubtful debts |
32.96 |
Bad debts/irrecoverable loans advances written off (net off provisions written-back) |
(44.83) |
Unrealised foreign exchange (including mark-to-market on currency and interest rate swaps) |
966.69 |
Realised foreign exchange on mark-to-market on currency and interest rate swaps |
(303.20) |
Interest income |
(52.20) |
Profit on Sale of Business/Investment |
(142.72) |
Dividend on non-trade current investments |
- |
|
7,565.99 |
Operating cash flow before working capital changes |
9,638.82 |
(Increase)/Decrease in trade receivables, loans and advances and other assets |
507.37 |
Decrease/(increase) in inventories |
(1,750.04) |
Increase in trade payables, provisions and other liabilities |
135.81 |
Cash generated from operations |
8,531.82 |
Income tax and wealth tax paid (net of refund) |
(809.11) |
Net cash generated from operating activities |
7,722.71 |
Cash flow from investing activities :
|
|
Acquisition/purchase of fixed assets/Capital work-in-progress |
(2,908.08) |
Sale of fixed assets |
63.50 |
Purchase of investments |
(62.52) |
Sale of business |
407.11 |
Movement in other bank balances* |
702.83 |
Interest received |
52.93 |
Dividend received |
- |
Net cash used in investing activities |
(1,744.23) |
Cash flow arising from financing activities :
|
|
Proceeds from long term borrowings** |
5,163.79 |
Repayment of long term borrowings |
(6,233.20) |
Proceeds from short term borrowings (net of repayments) |
516.21 |
Net (payment)/ receipt on settlement of currency and interest rate swaps |
303.34 |
Payment to Minority |
- |
Receipt of capital subsidy |
3.00 |
Dividend paid (including dividend distribution tax) |
(552.36) |
Finance costs paid |
(3,344.86) |
Net cash used in financing activities |
(4,144.08) |
Effect of exchange rate changes |
114.26 |
Net (decrease)/increase in cash and cash equivalents (A+B+C+D) |
1,948.66 |
Add: cash and cash equivalents at the beginning of year |
2,796.47 |
Adjustment: cash and cash equivalents on sale of business of Asia Healthcare Development Limited (Refer note 33) |
(10.28) |
Adjustment: cash and cash equivalents on (deconsolidation)/consolidation of ESOP trust (Refer note40) |
0.06 |
Cash and cash equivalents at the close of the year |
4,734.91 |
Components of cash and cash equivalents |
|
Balances with banks:* |
|
- On current accounts |
4,546.12 |
On dividend accounts |
28.18 |
- On deposits accounts with original maturity upto three months |
104.95 |
Cash on hand |
2.29 |
Cheques/Drafts in hand |
0.23 |
Others |
|
- Funds in transit |
51.43 |
- Imprest |
1.71 |
|
4,734.91 |
* Rs. 83.08 million (Previous year Rs. 198.03 million) has restricted use.
** Revolver facility of Jubilant HollisterStier LLC is presented on net basis (Refer note 5.19). |